Heart transplantation for heart failure in children.
Heart transplantation has become standard therapy for end-stage heart failure in children with cardiomyopathy as well as complex congenital heart disease, and has a significant effect on survival and quality of life. The indications for listing and referral for transplantation are outlined. Evaluation for heart transplantation is discussed, including full pretransplant assessment. ABO incompatible listing and HLA sensitization are discussed, and listing algorithms are outlined for different countries.
Pahl
Elfriede
E
Department of Pediatrics, Children's Memorial Hospital, Northwestern Feinberg School of Medicine, 2300 Children's Pl, Cardiology Box 21, Chicago, IL 60614, USA. epahl@childrensmemorial.org
Dipchand
Anne I
AI
Burch
Michael
M
D000017:ABO Blood-Group System; D001787:Blood Group Incompatibility / Q000175:diagnosis; D002648:Child; D000075202:Contraindications; D005080:Exercise Test; D006084:Graft Rejection / Q000276:immunology; D006680:HLA Antigens / Q000276:immunology; D006331:Heart Diseases / Q000150:complications; D006333:Heart Failure / Q000145:classification / Q000209:etiology / Q000601:surgery*; D016027:Heart Transplantation; D006650:Histocompatibility Testing; D006801:Humans; D018579:Patient Selection; D011300:Preoperative Care; D014850:Waiting Lists
D000017:ABO Blood-Group System; D006680:HLA Antigens